NO983666D0 - Krystallmodifikasjon av et farmasöytisk middel - Google Patents

Krystallmodifikasjon av et farmasöytisk middel

Info

Publication number
NO983666D0
NO983666D0 NO983666A NO983666A NO983666D0 NO 983666 D0 NO983666 D0 NO 983666D0 NO 983666 A NO983666 A NO 983666A NO 983666 A NO983666 A NO 983666A NO 983666 D0 NO983666 D0 NO 983666D0
Authority
NO
Norway
Prior art keywords
pharmaceutical agent
crystal modification
crystal
modification
pharmaceutical
Prior art date
Application number
NO983666A
Other languages
English (en)
Other versions
NO329314B1 (no
NO983666L (no
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983666(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO983666D0 publication Critical patent/NO983666D0/no
Publication of NO983666L publication Critical patent/NO983666L/no
Publication of NO329314B1 publication Critical patent/NO329314B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
NO19983666A 1997-06-10 1998-08-11 Krystallmodifikasjon av et farmasoytisk middel, anvendelse derav samt farmasoytisk preparat inneholdende krystallmodifikasjonen. NO329314B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003428 WO1998056773A1 (en) 1997-06-10 1998-06-08 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic

Publications (3)

Publication Number Publication Date
NO983666D0 true NO983666D0 (no) 1998-08-11
NO983666L NO983666L (no) 1998-12-17
NO329314B1 NO329314B1 (no) 2010-09-27

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983666A NO329314B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av et farmasoytisk middel, anvendelse derav samt farmasoytisk preparat inneholdende krystallmodifikasjonen.
NO19983667A NO329315B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av forbindelse, farmasoytiske preparater inneholdende denne og anvendelse av krystallmodifikasjonen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19983667A NO329315B1 (no) 1997-06-10 1998-08-11 Krystallmodifikasjon av forbindelse, farmasoytiske preparater inneholdende denne og anvendelse av krystallmodifikasjonen.

Country Status (37)

Country Link
US (6) US6740669B1 (no)
EP (2) EP0994864B1 (no)
JP (2) JP3672575B2 (no)
KR (2) KR100409168B1 (no)
CN (3) CN1159300C (no)
AR (4) AR012946A1 (no)
AT (2) ATE232852T1 (no)
AU (2) AU725517B2 (no)
BR (2) BR9804947A (no)
CA (3) CA2614926C (no)
CO (2) CO4940448A1 (no)
CY (1) CY2007014I1 (no)
CZ (2) CZ292481B6 (no)
DE (3) DE69811500T2 (no)
DK (2) DK0994864T3 (no)
ES (2) ES2197485T3 (no)
FR (1) FR07C0037I2 (no)
HK (3) HK1028241A1 (no)
HU (2) HU225153B1 (no)
ID (2) ID21014A (no)
IL (2) IL125732A (no)
LU (1) LU91345I2 (no)
MY (2) MY120156A (no)
NL (1) NL300284I2 (no)
NO (2) NO329314B1 (no)
NZ (2) NZ331371A (no)
PE (2) PE79799A1 (no)
PL (2) PL192114B1 (no)
PT (1) PT994864E (no)
RU (2) RU2194041C2 (no)
SI (2) SI0994863T1 (no)
SK (2) SK283734B6 (no)
TR (2) TR199801630T1 (no)
TW (2) TW403740B (no)
UY (1) UY25844A1 (no)
WO (2) WO1998056772A1 (no)
ZA (2) ZA984966B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CA2486174A1 (en) * 2002-05-31 2003-12-11 Schering Corporation Xanthine phosphodiesterase v inhibitor polymorphs
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) * 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
RU2594155C2 (ru) * 2009-09-04 2016-08-10 Тэктикал Терапеутикс, Инк Новые композиции и способы получения 5-амино- или замещенных амино-1,2,3-триазолов и триазол-оротатных композиций
EP2563766B1 (en) * 2010-04-30 2014-06-25 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
ITMI20110718A1 (it) * 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
WO1991001724A1 (en) 1989-07-27 1991-02-21 G.D. Searle & Co. Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
EP0556393B1 (en) 1990-11-06 2000-07-26 Yamanouchi Pharmaceutical Co. Ltd. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
KR100419355B1 (ko) 1995-02-22 2004-06-04 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 무정형피레타나이드,피레타나이드다형체,이들의제조방법및이를포함하는약제학적조성물
SK283990B6 (sk) * 1996-07-11 2004-07-07 Novartis Ag Spôsob prípravy 1-substituovaných 4-kyano-1,2,3-triazolov, 4-kyano-1-(2,6-difluórbenzyl)-1H-1,2,3-triazol
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
HUP0000798A2 (hu) 2000-10-30
CY2007014I2 (el) 2009-11-04
CZ292260B6 (cs) 2003-08-13
FR07C0037I1 (no) 2007-08-17
EP0994864A1 (en) 2000-04-26
PE80999A1 (es) 1999-09-06
AR012945A1 (es) 2000-11-22
SK109498A3 (en) 1998-12-02
NO329315B1 (no) 2010-09-27
BR9804947A (pt) 1999-08-24
AU725517B2 (en) 2000-10-12
DE69811500D1 (de) 2003-03-27
JP3672575B2 (ja) 2005-07-20
HUP0002113A2 (hu) 2001-02-28
TW403740B (en) 2000-09-01
PE79799A1 (es) 1999-09-03
CZ253398A3 (cs) 1999-04-14
SK109398A3 (en) 1998-12-02
NO329314B1 (no) 2010-09-27
CA2256013C (en) 2007-10-16
CO4940452A1 (es) 2000-07-24
CN1298708C (zh) 2007-02-07
PT994864E (pt) 2003-07-31
HU225153B1 (en) 2006-07-28
US7750028B2 (en) 2010-07-06
CA2256015A1 (en) 1998-12-17
DE69811500T2 (de) 2004-04-01
HK1028241A1 (en) 2001-02-09
CA2256013A1 (en) 1998-12-17
DK0994864T3 (da) 2003-07-21
US20100310655A1 (en) 2010-12-09
PL192114B1 (pl) 2006-08-31
NL300284I2 (nl) 2007-11-01
ATE232852T1 (de) 2003-03-15
CN1132820C (zh) 2003-12-31
US20040167186A1 (en) 2004-08-26
CY2007014I1 (el) 2009-11-04
AR061004A2 (es) 2008-07-30
HK1028031A1 (en) 2001-02-02
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
ATE237599T1 (de) 2003-05-15
CA2614926C (en) 2010-02-09
KR19990087836A (ko) 1999-12-27
SK283685B6 (sk) 2003-12-02
SI0994864T1 (en) 2003-10-31
NO983666L (no) 1998-12-17
EP0994863A1 (en) 2000-04-26
US8076362B2 (en) 2011-12-13
IL125733A (en) 2002-12-01
JP3672574B2 (ja) 2005-07-20
NZ331370A (en) 2000-08-25
ZA984966B (en) 1999-01-11
DE69813560D1 (de) 2003-05-22
RU2198167C2 (ru) 2003-02-10
CO4940448A1 (es) 2000-07-24
AU8437298A (en) 1998-12-30
DE69813560T2 (de) 2004-02-05
PL330798A1 (en) 1999-06-07
NZ331371A (en) 2000-08-25
MY120156A (en) 2005-09-30
RU2194041C2 (ru) 2002-12-10
EP0994864B1 (en) 2003-04-16
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
US6455556B2 (en) 2002-09-24
DE122007000051I1 (de) 2007-11-08
ID21014A (id) 1999-04-08
HUP0002113A3 (en) 2002-09-30
US20030125568A1 (en) 2003-07-03
US20010037029A1 (en) 2001-11-01
UY25844A1 (es) 2001-08-27
NO983667L (no) 1998-12-17
KR100425656B1 (ko) 2004-05-17
WO1998056772A1 (en) 1998-12-17
KR100409168B1 (ko) 2004-01-31
IL125733A0 (en) 1999-04-11
CA2614926A1 (en) 1998-12-17
PL330764A1 (en) 1999-05-24
KR19990087835A (ko) 1999-12-27
CA2256015C (en) 2008-06-03
AU725528B2 (en) 2000-10-12
ES2197485T3 (es) 2004-01-01
SI0994863T1 (en) 2003-08-31
BR9804946A (pt) 1999-08-24
TW526195B (en) 2003-04-01
JP2000516259A (ja) 2000-12-05
DK0994863T3 (da) 2003-05-26
HUP0000798A3 (en) 2000-10-30
CZ292481B6 (cs) 2003-09-17
MY125854A (en) 2006-08-30
ZA984967B (en) 1999-01-11
US20060116520A1 (en) 2006-06-01
CN1259127A (zh) 2000-07-05
IL125732A (en) 2002-12-01
EP0994863B1 (en) 2003-02-19
PL191943B1 (pl) 2006-07-31
IL125732A0 (en) 1999-04-11
LU91345I9 (no) 2018-12-31
CZ253498A3 (cs) 1999-04-14
DE122007000051I2 (de) 2009-02-19
US6740669B1 (en) 2004-05-25
ID27660A (id) 2001-04-19
AR012946A1 (es) 2000-11-22
HK1028242A1 (en) 2001-02-09
CN1159300C (zh) 2004-07-28
AU8437198A (en) 1998-12-30
CN1217716A (zh) 1999-05-26
LU91345I2 (fr) 2007-09-04
AR061005A2 (es) 2008-07-30
HU226107B1 (en) 2008-04-28
CN1572789A (zh) 2005-02-02
ES2192779T3 (es) 2003-10-16
FR07C0037I2 (no) 2008-05-16
TR199801630T1 (xx) 1999-06-21
JP2000516258A (ja) 2000-12-05
TR199801631T1 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
NO331016B1 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat
MA26497A1 (fr) Nouvelle formulation pharmaceutique
FI971279A (fi) Lääkkeitä
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
FI973243A (fi) Uusi farmaseuttinen yhdistelmä
NO982809L (no) Prolegemidler av tombin-inhibitorer
ATE239481T1 (de) Filmueberzogene tabletten von oxacarbazepin
NO980546D0 (no) Farmasöytiske midler
NL300284I2 (nl) Kristalmodificatie van
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
BR9610214A (pt) Compostos farmacéuticos
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
NO20042393L (no) Polymorf av et farmakum
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
DE69823908D1 (de) Einkristallziehvorrichtung
NO20000811D0 (no) Fremgangsmåte for valg av medicament
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO965448L (no) Farmasöytiske forbindelser
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
DE29517296U1 (de) Medikamententimer
SE9503711D0 (sv) New pharmaceutical carrier
SE9402131D0 (sv) Läkemedel

Legal Events

Date Code Title Description
MK1K Patent expired